Tesevatinib receives FDA orphan drug designation for the treatment of ARKPD March 4, 2016 No Comments
Oxalate descarboxylase receives FDA orphan drug designation for pediatric hyperoxaluria March 3, 2016 No Comments
Thrasos announces successful outcome to phase II trial of THR-184 to prevent acute kidney injury March 1, 2016 No Comments
Cytori Cell Therapy improves erectile dysfunction after radical prostatectomy Feb. 5, 2016 No Comments
A new patent listed and additional orphan drug designation granted for Procysbi in the U.S. Jan. 27, 2016 No Comments
RSS